Industry News
Leap frogging in muscle research
Can a frog that is known to bury itself in mud for months on end hold the key to avoiding muscle wastage in people with broken bones?
[ + ]Swinburne IT students create innovative software
Swinburne TAFE information technology students have created a range of innovative software packages. Two of the packages will influence communications within the Australian Department of Defence and assist in vital research being conducted at Monash University into the structure of proteins.
[ + ]Light factories: going one better than nature
Researchers are attempting to perfect photosynthesis, a process pioneered by plants and bacteria, in an ambitious scheme to generate new foods, fabrics and even electricity, sustainably.
[ + ]Genome solved -- hunt for vaccine targets begins
The genes of a bacterium that can kill or cause permanent organ damage in humans have been identified by Monash University researchers, whose efforts are now focused on finding a suitable vaccine.
[ + ]Smart GM plants win CSIRO's top award
Research that has led to new cotton varieties with increased yield and reduced pesticide use has won this year's CSIRO Chairman's Medal.
[ + ]Benitec, CSIRO, QDPI resolve gene-silencing dispute
The big legal guns have fallen silent, and Queensland biotechnology company Benitec (ASX:BLT), CSIRO and Queensland's Department of Primary Industries have shaken hands on a landmark agreement that will allow CSIRO and Benitec to pursue their commercialisation of the revolutionary gene-silencing tool known as DNA-directed RNA interference (ddRNAi). [ + ]
Critical mass key to investor support: Vernalis CEO
Small biotech companies face investor resistance to mergers and acquisitions, a leading British biotech CEO told attendees at a briefing in Melbourne on Tuesday. [ + ]
UK firm Vernalis testing Monash painkiller
New British biotech company Vernalis expects to complete Phase I clinical trials of a powerful new painkiller discovered by Monash University scientists by the middle of next year. [ + ]
Milestone strategic agreement to commercialise Australian biotech innovation
Benitec Limited, CSIRO and the Queensland Department of Primary Industries, have announced a strategic agreement that will accelerate Australia's lead in the global commercialisation of DNA Directed RNA interference, a breakthrough gene silencing technology.
[ + ]CogState aims to raise $5.5m at IPO
The latest company to jump on the IPO bandwagon is CogState, which filed its prospectus with the ASX mid-last week. [ + ]
Our first genome: Leptospira genome completed
Australian researchers have their first bug in the bank: a full genome map and complete DNA sequence of the 3900-odd genes that make up the spirochete bacterium Leptospira. [ + ]
Pulsar find boosts hope for gravity-wave hunters
A discovery made with CSIRO's Parkes radio telescope in eastern Australia may have brought forward the day when astronomers will directly detect cosmic gravity waves for the first time.
[ + ]Scientists refute aspects of UK Farm Scale GM study
A group of leading international agricultural and food scientists says increased food production by GM herbicide-tolerant crops could actually benefit the environment and enhance biodiversity in Britain and Europe by allowing unused farmland to rededicated as conservation reserves. [ + ]
Cluster power ending Australia's research computing drought
If computing power were water, Australia's drought would be rapidly coming to a close. Thanks to lowering costs and steadily improving technology, Australian life scientists and other researchers are rapidly gaining access to unprecedented amounts of computing power to support their work. [ + ]
Novogen subsidiary raises US$10m
Marshall Edwards, the US subsidiary of Novogen (ASX:NRT), has raised US$10.1 million through the exercise of expiring warrants by shareholders. [ + ]